Werewolf Therapeutics IncNASDAQ:HOWL
- LAST PRICE5.7900
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots5.3000/ 1
- Ask / Lots6.0100/ 39
- Open / Previous Close5.5500 / 5.7900
- Day Range
- 52 Week Range
- Volume137,954
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | HOWL |
|---|---|---|
| 09:36 ET | 1288 | 5.55 |
| 09:38 ET | 1500 | 5.53 |
| 09:54 ET | 1186 | 5.6783 |
| 10:01 ET | 1485 | 5.7 |
| 10:03 ET | 100 | 5.74 |
| 10:10 ET | 576 | 5.87 |
| 10:17 ET | 7600 | 5.795 |
| 10:19 ET | 1665 | 5.78 |
| 10:21 ET | 800 | 5.79 |
| 10:26 ET | 371 | 5.76 |
| 10:30 ET | 100 | 5.76 |
| 10:32 ET | 100 | 5.76 |
| 10:37 ET | 150 | 5.6562 |
| 10:42 ET | 100 | 5.76 |
| 11:00 ET | 2130 | 5.7 |
| 11:02 ET | 300 | 5.675 |
| 11:06 ET | 495 | 5.7 |
| 11:09 ET | 5600 | 5.65 |
| 11:11 ET | 7364 | 5.59 |
| 11:15 ET | 100 | 5.59 |
| 11:22 ET | 8247 | 5.47 |
| 11:24 ET | 100 | 5.47 |
| 11:26 ET | 100 | 5.47 |
| 11:38 ET | 300 | 5.47 |
| 11:40 ET | 44763 | 5.6 |
| 11:58 ET | 100 | 5.53 |
| 01:30 ET | 100 | 5.73 |
| 01:53 ET | 1000 | 5.8809 |
| 02:00 ET | 400 | 5.85 |
| 02:11 ET | 100 | 5.79 |
| 02:20 ET | 100 | 5.94 |
| 02:29 ET | 100 | 5.93 |
| 02:31 ET | 726 | 5.908 |
| 02:40 ET | 100 | 5.9 |
| 02:44 ET | 250 | 5.9016 |
| 02:47 ET | 200 | 5.93 |
| 02:54 ET | 1011 | 5.8375 |
| 03:02 ET | 500 | 5.94 |
| 03:05 ET | 100 | 5.94 |
| 03:12 ET | 200 | 5.94 |
| 03:39 ET | 146 | 5.88 |
| 03:41 ET | 200 | 5.92 |
| 03:48 ET | 100 | 5.86 |
| 03:52 ET | 100 | 5.885 |
| 03:54 ET | 2086 | 5.8108 |
| 03:56 ET | 4288 | 5.87 |
| 03:57 ET | 1500 | 5.805 |
| 03:59 ET | 7256 | 5.79 |
Aug 3, 2022
Werewolf Therapeutics to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference, from 7:00AM ET on Wednesday Aug 03, 2022 by GlobeNewswire
7:00AM ET on Wednesday Aug 03, 2022 by GlobeNewswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Werewolf Therapeutics Inc | 160.1M | -1.0x | --- |
Immunic Inc | 162.8M | -1.8x | --- |
TFF Pharmaceuticals Inc | 162.6M | -5.1x | --- |
Portage Biotech Inc | 156.9M | -7.2x | --- |
Celcuity Inc | 156.1M | -4.2x | --- |
Enzolytics Inc | 164.2M | -0.6x | --- |
Company Information
Werewolf Therapeutics, Inc. is a biopharmaceutical company focused on developing a pipeline of cancer treatments. The Company is developing immuno-stimulatory therapeutics designed to act selectively within the tumor microenvironment to enhance the body’s immune response to cancer. The Company’s product candidates include WTX-124, WTX-330 and WTX-613. The Company’s advanced product candidates, WTX-124 and WTX-330, are systemically delivered, conditionally activated Interleukin-2 (IL-2), and Interleukin-12 (IL-12). Its INDUKINE molecules for the treatment of solid tumors. The Company initiating a Phase I/Ib clinical trial for each candidate in multiple tumor types as a single agent and in combination with an immune checkpoint inhibitor. WTX-613 is designed to have minimal activity in the periphery and is activated preferentially in the tumor microenvironment (TME) to release wild-type IFNα in the tumor and potentially stimulate an anti-tumor immune response.
Contact Information
- Headquarters
- 200 Talcott Avenue, 2Nd FloorWATERTOWN, MA, United States 02472
- Phone
- 617-952-0555
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Luke Evnin
- President, Chief Executive Officer, Director
- Daniel Hicklin
- Chief Financial Officer, Treasurer
- Timothy Trost
- Chief Operating Officer
- Reid Leonard
- Chief Technology Officer
- Chulani Karunatilake
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $160.1M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 27.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-5.54 |
Book Value | $5.59 |
P/E Ratio | -1.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
